Hypothesis Comparison

⚛ Collide these

Comparing 1 hypotheses side-by-side

|

ALOX15 Inhibition Combined with Selenium Augmentation for Synergistic Ferroptosi

ALOX15, SELENOP · - · -
Composite
0.580
Price
$0.56
Evidence For
6
Evidence Against
5

15-lipoxygenase (ALOX15) catalyzes peroxidation of arachidonic acid-containing phospholipids, a key step in ferroptosis execution. Combined pharmacological inhibition of ALOX15 plus selenium supplementation to augment selenoprotein biosynthesis would provide synergistic blockade at both initiation and execution phases.

Radar Chart — 10 Dimensions

Score Comparison Bars

Mechanistic
0.72
Evidence
0.58
Novelty
0.70
Feasibility
0.38
Impact
0.58
Druggability
0.45
Safety
0.50
Competition
0.75
Data
0.55
Reproducible
0.60

Score Breakdown

DimensionALOX15 Inhibition Combined wit
Mechanistic0.720
Evidence0.580
Novelty0.700
Feasibility0.380
Impact0.580
Druggability0.450
Safety0.500
Competition0.750
Data0.550
Reproducible0.600

Evidence

ALOX15 Inhibition Combined with Selenium Augmentation for Sy

Supporting Evidence
Upregulated ALOX15 contributes to lipid peroxidation in SOD1G93A motor neurons PMID:36443440
Upregulated ALOX15 contributes to lipid peroxidation in SOD1G93A motor neurons PMID:35178161
MPO/HOCl facilitates ferroptosis in SOD1G93A motor neurons PMID:35178161
GPX4 is the central repressor of ferroptosis by reducing phospholipid hydroperoxides PMID:24439385
Combined targeting addresses both GPX4-dependent and independent ferroptosis pathways PMID:40022222
Contradicting Evidence
Selenium supplementation alone has not emerged as effective ALS therapy despite decades of interest PMID:9726810
ML351 ALOX15 inhibitor has not advanced beyond preclinical development - pharmaceutical industry largely abandoned LOX i PMID:FEASIBILITY_ASSESSMENT
Dual-target complication increases regulatory burden, dosing complexity, and drug-drug interactions PMID:FEASIBILITY_ASSESSMENT

Debate Excerpts

ALOX15 Inhibition Combined with Selenium Augmentat

5 rounds · quality: 0.59

Theorist

Based on my comprehensive research gathering literature evidence and computational findings, I now present 6 novel therapeutic hypotheses for ferroptosis in ALS and motor neuron diseases. --- ## N...

Skeptic

# Critical Evaluation of Ferroptosis-Based Therapeutic Hypotheses for ALS ## Overview and Major Concerns Before evaluating individual hypotheses, several overarching issues must be addressed: **1...

Domain Expert

# Practical Feasibility Assessment: Ferroptosis-Based Therapeutic Hypotheses for ALS ## Executive Summary Of the seven hypotheses presented, **five survive critical evaluation with sufficient tran...

Synthesizer

{"ranked_hypotheses":[{"title":"GPX4 Selenopeptide Mimetics as Neuroprotective Ferroptosis Blockade","description":"Small molecule mimetics of the GPX4 selenopeptide active site (Sec-γ-Glu-Cys-Gly) ...

Price History Overlay